Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$0.28 - $1.16 $1,184 - $4,906
4,230 Added 12.29%
38,647 $12,000
Q1 2024

May 06, 2024

BUY
$1.06 - $1.67 $7,936 - $12,503
7,487 Added 27.8%
34,417 $39,000
Q3 2023

Nov 01, 2023

BUY
$1.61 - $2.54 $16,127 - $25,443
10,017 Added 59.23%
26,930 $48,000
Q2 2023

Jul 27, 2023

BUY
$1.14 - $1.95 $19,280 - $32,980
16,913 New
16,913 $31,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $11.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Empowered Funds, LLC Portfolio

Follow Empowered Funds, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.